TrialAdvances in therapy2022

Population Pharmacokinetics and Exposure-Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B Cell Lymphoma.

Divya Samineni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.